TopStockPlays.com brings you the most vibrant coverage of these - AMGN, ARNA, DNDN, ACAD
Pompano Beach, FL -- (SBWIRE) -- 01/24/2013 -- Amgen, Inc. (NASDAQ:AMGN) the price of the stock moved down-0.26% and finished the day at $83.07 on above average volume. The day started out with a higher opening price of $83.06 versus prior close of $84.49. The total number of shares traded on the latest trading day was about 7.67 million shares, and changed hands at average prices of $82.87 to $84.49 apiece.
Amgen, Inc. the one of the world’s biggest biotechnology companies, reported profits for its fiscal fourth-quarter which topped analyst estimates as sales of arthritis and bone drugs surged up.
Where AMGN is Headed Exactly? Find out in This Trend Analysis Reports
The shares declined about -3.63% since the start of 2013 and has a -7.09% loss in last three months. Narrowing down the performance period, the stock fell -6.04% for the month and a -2.36% gain over the week.
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) traded in a range of $8.64 to $8.85, completing the day down-$0.14, or -1.59% to$8.68. The total volume of shares exchanged was 6.62 million. The stock was at -3.77% as on Jan 23, 2013 for this year as compared to 435.80% in the last 12 months. The company established a 52-week high of $13.50 on Jun 27, 2012 and is now -35.70% down than that level.
Arena Pharmaceuticals, Inc. reported that it has received the Day 180 List of Exceptional Issues from the Committee for Medicinal Products for Human Use, or CHMP, it is a European Medicines Agency.
Can ARNA Show a Strong Recovery? Find out in This Research Report
Dendreon Corporation (NASDAQ:DNDN)The stock has now dropped about -3.14% from its record high price level, and has advanced by 16.64% for this year.
Latest close brings its distance from its 52-week low at +67.21%. The stock has a PE ratio and their market value is $952.14M. It closed at $6.17, trading 0.87% above its 200 day moving average and 21.94% above its 50 day moving average.
Should DNDN a Buy or Sell Now? Find Out Here
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) remained a bull for the day as it reported the upward momentum of +3.53% and closed at $5.87 after gaining total volume of 5.25million shares.
ACAD’s year to date performance remained quite optimistic with the gain of 26.24% while in last 6 months it gained almost 276.28%. During Last three months company reported a upward momentum of 136.69%. ACAD has the total of 59.66 million outstanding shares and its total market capitalization is $350.18 million.
What ACAD’s Charts Are Signaling for Traders? Find Out Here
The TopStockPlays.com expert team is highly experienced in picking the low-priced shares with the biggest profit potential. We uncover the hidden gems in the stock market-shares that can break out for gains of 300%, 400%, even 500% within a few weeks.
PLEASE NOTE WELL: The TopStockPlays.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. Please do your research or consults your financial adviser before making any Investment decision. TopStockPlays.com or its employees will not be responsible for any loss or losses.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)